Skip to content

    Birth Control Health Center

    Font Size
    A
    A
    A

    New Warning for Some Birth Control Pills

    Pills Containing Drospirenone Will Warn of Blood Clot Risk on Labels
    By
    WebMD Health News
    Reviewed by Laura J. Martin, MD

    April 10, 2012 -- Birth control pills that contain the hormone drospirenone must now carry a warning that they may increase the risk for potentially fatal blood clots, according to the FDA.

    Drospirenone is a synthetic version of the female sex hormone progesterone. Birth control pills containing this hormone include Bayer Healthcare Pharmaceutical's Beyaz, Safyral, Yasmin, and Yaz brands, as well as several other brands (Gianvi, Loryna, Ocella, Syeda, and Zarah).

    The new action is the result of an extensive review of the literature. The FDA stated that manufacturers must add information to product labels about studies linking these birth control pills to blood clot risks. The revised drug labels will state that some studies have found as high as a threefold increase in the risk of blood clots among women taking these contraceptives, compared with those who took other progestin-containing pills. Other studies found no additional risk of blood clots.

    Women should talk to their doctors about their risk for blood clots before choosing a birth control method, the FDA states.

    Today on WebMD

    IUD
    Here's what to expect.
    man opening condom wrapper
    Do you know the right way to use them?
     
    birth control pills
    Here's what to do next.
    intimate couple in bed
    Take this quiz.
     
    Road sign reading change ahead
    Article
    teen couple holding hands
    Article
     
    pregnancy test and calendar
    Article
    Birth Control Pills Weight Gain
    Article
     
    contraceptive pills
    Slideshow
    Young couple looking at each other, serious
    Article
     
    woman reading pregnancy test result
    Article
    calendar
    Article